Squeeze or trap?

Before you buy a hyped small-cap, see what the company has filed with the SEC: share-sale programs, the real share count, reverse splits and insider trades. One report, straight from the filings.

See a sample reportPricing

Why the "130% shorted" posts are often wrong

Data sites update a company's share count from its quarterly report. A company selling new shares every day can be far ahead of that number. In our CENN sample, sites showed about 2.5 million shares while the company's own filing said 37.6 million. Every "percent shorted" number built on the old count was about 15× too high.

The filings that tell you this are public. They are just long, scattered and easy to miss. DilutionCheck pulls them together.

What every report checks

Share-sale programs

At-the-market offerings, shelf registrations (S-3) and prospectus supplements (424B5): how much the company can sell and how much it already has.

Real share count

The latest count from the company's own filings, compared with the count most data sites still show.

Reverse splits

Past splits, and any split already approved but not yet done, including the ratio range.

Authorized shares

How many shares the company is allowed to issue, and whether that ceiling was raised.

Private placements

Shares sold directly to investors, the price they paid and when they closed.

Insider trades

Form 4 buys and sells by officers, directors and big holders.

Each report lists its sources with links to the SEC, so you can check every number yourself.

Pricing

$5 / 50 checks

10¢ per report. Good for checking the day's hyped tickers.

$20 / 250 checks

8¢ per report. For active traders.

One check = one ticker report. Credits never expire. Pay by card through Stripe. Refund policy.

Launching soon

What DilutionCheck is not

It doesn't tell you to buy or sell anything, predict prices or give personal advice. Every reader gets the same facts from the same filings. What you do with them is your call.